Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

Share Price is delayed by 15 minutes
Get Live Data
21.00    0.10 (0.48%)
Bid:
21.00
Ask:
22.00
Spread: 1.00 (4.762%)
Market Cap: €116.56b
BVA Live PriceLast checked at - London Stock Exchange

Intraday Bbva Ord Share Chart

2021 MREL Requirement

1 Jun 2021 07:00

RNS Number : 3047A
Banco Bilbao Vizcaya Argentaria SA
01 June 2021
 

 

 

 

Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA"), in compliance with the Securities Market legislation, hereby communicates the following:

INSIDE INFORMATION

BBVA has received a new communication from the Bank of Spain regarding its minimum requirement for own funds and eligible liabilities ("MREL"), as determined by the Single Resolution Board ("SRB"), that has been calculated taking into account the financial and supervisory information as of December 31, 2019[1], and which supersedes the previous MREL communication published on November 19, 2019.

In accordance with this new MREL communication, BBVA has to reach, by January 1, 2022, an amount of own funds and eligible liabilities equal to 24.78%[2] of the total risk weighted assets ("RWAs") of its resolution group, on sub-consolidated level[3] (the "MREL in RWAs"). Within this MREL in RWAs, an amount equal to 13.50%2 of the RWAs shall be met with subordinated instruments (the "subordination requirement in RWA").

This MREL in RWA is equal to 10.25% in terms of the total exposure considered for calculating the leverage ratio (the "MREL in LR"), while the subordination requirement in RWAs is equal to 5.84% in terms of the total exposure considered for calculating the leverage ratio (the "subordination requirement in LR").

The current own funds and eligible liabilities structure of the resolution group meets the MREL in RWAs, the MREL in LR, the subordination requirement in RWAs and the subordination requirement in LR.

 

MREL

 

% RWAs

% Leverage ratio (LR) exposure

Requirement as of January 1, 2022

24.78%

10.25%

Own funds and eligible liabilities as of March 31, 2021

29.23%[4]

13.40%

 

Subordination requirement

 

% RWAs

% Leverage ratio (LR) exposure

Requirement as of January 1, 2022

13.50%

5.84%

Own funds and eligible subordinated liabilities as of March 31, 2021

25.95%4

11.89%

 

 

Madrid, May 31, 2021

 

[1] As the reference date used for the calibration of the MREL has been December 31, 2019, the effects, among other issues, of the expected sale of the BBVA Group subsidiary BBVA USA Bancshares, Inc, which was announced to the market on November 16, 2020, have not been taken into account.

[2] In accordance with the new applicable regulation, the MREL in RWAs and the subordination requirement in RWAs do not include the combined capital buffer requirement. For these purposes, the applicable combined capital buffer requirement would be 2.5%, without prejudice to any other buffer that may be applicable at any time.

[3] Pursuant to BBVA Group's MPE (Multiple Point of Entry) resolution strategy, as established by the SRB, the resolution group consists of Banco Bilbao Vizcaya Argentaria S.A. and the subsidiaries that belong to the same European resolution group. As of December 31, 2019, the RWAs of the resolution group amounted to 204,218 million euros and the total exposure considered for calculating the leverage ratio amounted to 422,376 million euros.

[4] Own funds and eligible liabilities to meet both MREL in RWAs or subordination requirement in RWAs, as applicable, and the combined capital buffer requirement, which would be 2.5%, without prejudice to any other buffer that may apply at any time.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUAUKRAWUVOAR
Date   Source Headline
15th Jun 202610:14 amRNSPeriodic Report on the Buyback Program 15/06/2026
9th Jun 20265:09 pmRNSOIR redemption GMTN 167 (T2)
8th Jun 202610:19 amRNSPeriodic Report on the Buyback Program 08/06/2026
1st Jun 202610:20 amRNSPeriodic Report on the Buyback Program 01/06/2026
26th May 20267:00 amRNSPeriodic Report on the Buyback Program 25/05/2026
18th May 202610:18 amRNSPeriodic Report on the Buyback Program 18/05/2026
12th May 20266:23 pmRNSHR - Fitch rating upgrade
11th May 202610:17 amRNSPeriodic Report on the Buyback Program 11/05/2026
1st May 20267:00 amRNSIssue of preferred sec. contingently convertible
1st May 20267:00 amRNSChanges in BBVA’s Board of Directors
30th Apr 20268:39 amRNSShare Buyback Program
30th Apr 20267:19 amRNS1Q26 Earnings Presentation
30th Apr 20267:16 amRNS1Q26 Quarterly Report
30th Apr 20267:12 amRNSResults Press Release BBVA 1T2026
22nd Apr 20261:24 pmRNS1T26 Earnings Presentation Announcement
20th Apr 20267:00 amRNSCompletion of the execution of the Second Tranche
17th Apr 20267:14 amRNSEarly redemption of public sector covered bonds
15th Apr 20262:57 pmRNSBBVA Notice to amend final terms GMTN 29
14th Apr 20265:20 pmRNSMREL requirement
13th Apr 202610:19 amRNSPeriodic Report on the Buyback Program 13/04/2026
7th Apr 20267:00 amRNSPeriodic Report on the Buyback Program 06/04/2026
31st Mar 20265:50 pmRNSBBVAs share capital reduction
23rd Mar 20267:00 amRNSPilar 3 Report 2025
20th Mar 202611:50 amRNSShare Buyback Program
6th Mar 20266:19 pmRNSCompletion of the execution of the First Tranche
2nd Mar 202610:18 amRNSPeriodic Report on the Buyback Program 2026/03/02
23rd Feb 202610:29 amRNSPeriodic Report on the Buyback Program 23/02/2026
19th Feb 202610:46 amRNS2025_Individual_Annual_Accounts_and_Management_Rep
19th Feb 202610:37 amRNS2025_Cons_Annual_Accounts_and_Management_Report
16th Feb 202610:24 amRNSPeriodic Report on the Buyback Program 2026/02/16
13th Feb 20265:22 pmRNSApril dividend calendar
13th Feb 20263:33 pmRNS2026 AGM Notice and Proposed Resolutions
11th Feb 20265:44 pmRNSEarly redemption of Senior Preferred Notes
10th Feb 20267:00 amRNS2026 Annual General Meeting Call
9th Feb 202610:11 amRNSPeriodic Report on the Buyback Program 2026/02/09
5th Feb 20267:00 amRNSShareholder remuneration for 2025
5th Feb 20267:00 amRNS4Q25 Earnings Report
5th Feb 20267:00 amRNS4Q25 Earnings Press Release
5th Feb 20267:00 amRNS4Q25 Earnings Presentation
2nd Feb 202610:27 amRNSPeriodic Report on the Buyback Program 02/02/2026
28th Jan 20261:29 pmRNS4Q25 Earnings Presentation Announcement
27th Jan 20267:00 amRNSNew Periodic Report Buyback Program 26/01/2026
26th Jan 202610:30 amRNSPeriodic Report on the Buyback Program 26/01/2026
19th Jan 202610:06 amRNSPeriodic Report on the Buyback Program 19/01/2026
12th Jan 202610:18 amRNSPeriodic Report on the Buyback Program 12/01/2026
2nd Jan 202610:39 amRNSPeriodic Report on the Buyback Program 02/01/2026
23rd Dec 20255:28 pmRNSBBVA's share capital reduction
23rd Dec 20255:28 pmRNSBBVA's share capital reduction
19th Dec 20257:21 amRNSShare Buyback Program
19th Dec 20257:21 amRNSShare Buyback Program

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.